Paterson Dan 4

What Happened Dan Paterson, President, CEO and a director of Verastem, was granted 213,785 restricted stock units (RSUs) on January 21, 2026 (transaction code A). The grant was reported on a Form 4 filed January 23, 2026. The RSUs carry a reported acquisition price of $0.00 (this reflects a compensation award, not a cash purchase); they represent the contingent right to receive one share of Verastem common stock per RSU upon vesting.

Key Details

• Transaction date: January 21, 2026; Form 4 filed: January 23, 2026 (no indication of a late filing).
• Grant size and price: 213,785 RSUs granted at $0.00 each (award/compensation, not an open‑market buy).
• Shares owned after transaction: not stated in the provided filing.
• Vesting: RSUs vest as to 33.3% on each of the first three anniversaries of Jan 21, 2026 and fully vest on Jan 21, 2029; vesting amounts are rounded down to whole RSUs with any remainder vesting on the final date (see footnote F1).
• Footnote: Award made under the Issuer’s Amended and Restated 2021 Equity Incentive Plan; RSUs convert to shares only upon vesting and require continued service.

Context RSU grants are a form of compensation and do not involve an immediate cash purchase or sale of stock. Because these RSUs vest over time and are forfeitable if the recipient leaves before vesting, they signal long‑term incentive alignment rather than a near‑term bullish purchase. No sales, open‑market purchases, option exercises, or unusual filing issues are indicated in this report.